GPR133 Promotes Glioblastoma Growth in Hypoxia
- 1 September 2017
- journal article
- conference paper
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 64 (CN_suppl_1) , 177-181
Abstract
No abstract availableFunding Information
- National Institutes of Health (1R21NS074055-02, 1R21NS087241-01, 1R21NS088775-01, 1R03NS087349-01, 2P30CA016087-33, UL1 TR000038)
This publication has 26 references indexed in Scilit:
- Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cellsNature Communications, 2015
- Selective Lentiviral Gene Delivery to CD133-Expressing Human Glioblastoma Stem CellsPLOS ONE, 2014
- Glioblastoma stem cells: Molecular characteristics and therapeutic implicationsWorld Journal of Stem Cells, 2014
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheresMolecular Cancer, 2010
- A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2αBrain, 2010
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem CellsCancer Cell, 2009
- Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth FactorCancer Research, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Identification of human brain tumour initiating cellsNature, 2004